Atlas Trials

Paolo Caimi, MD

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Paolo Caimi, MD

RecordFirmDate
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) (NCT07225439)Paolo Caimi, MD2026-09-01
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (NCT06916767)Paolo Caimi, MD2025-07-15
Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma (NCT05053659)Paolo Caimi, MD2022-06-20

Track Paolo Caimi, MD automatically

Every clearance here is in the API, with alerts when new ones post.